{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:46:45Z","timestamp":1789818405104,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jim.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T01:00:51Z","timestamp":1493859651000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infection"],"prefix":"10.1016","volume":"448","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0042-9232","authenticated-orcid":false,"given":"Nora","family":"Pisanic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-6683","authenticated-orcid":false,"given":"Atiqur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir K.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain B.","family":"Labrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenrad E.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve W.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Detrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jim.2017.04.012_bb0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1590\/S0074-02762006000200006","article-title":"Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies","volume":"101","author":"Amado","year":"2006","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"11","key":"10.1016\/j.jim.2017.04.012_bb0010","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/jmv.24251","article-title":"Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection","volume":"87","author":"Avellon","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jim.2017.04.012_bb0015","series-title":"L. WANTAI HEV-IgG ELISA","author":"Beijing Wantai Biological Pharmacy Enterprise Co.","year":"2014"},{"issue":"5","key":"10.1016\/j.jim.2017.04.012_bb0020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jmv.21656","article-title":"A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries","volume":"82","author":"Bendall","year":"2010","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.jim.2017.04.012_bb0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1196\/annals.1384.012","article-title":"Do salivary antibodies reliably reflect both mucosal and systemic immunity?","volume":"1098","author":"Brandtzaeg","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jim.2017.04.012_bb0030","doi-asserted-by":"crossref","DOI":"10.3402\/jom.v5i0.20401","article-title":"Secretory immunity with special reference to the oral cavity","volume":"5","author":"Brandtzaeg","year":"2013","journal-title":"J. Oral Microbiol."},{"issue":"3","key":"10.1016\/j.jim.2017.04.012_bb0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3343\/alm.2013.33.3.184","article-title":"Performance evaluation of the OraQuick hepatitis C virus rapid antibody test","volume":"33","author":"Cha","year":"2013","journal-title":"Ann. Lab. Med."},{"issue":"2","key":"10.1016\/j.jim.2017.04.012_bb0040","first-page":"237","article-title":"Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies","volume":"17","author":"Chaushu","year":"1996","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.jim.2017.04.012_bb0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect. Dis."},{"issue":"12","key":"10.1016\/j.jim.2017.04.012_bb0050","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/01.aids.0000238412.75324.82","article-title":"Performance of an oral fluid rapid HIV-1\/2 test: experience from four CDC studies","volume":"20","author":"Delaney","year":"2006","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jim.2017.04.012_bb0055","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1086\/654801","article-title":"Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances","volume":"51","author":"Drobeniuc","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.jim.2017.04.012_bb0060","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2105\/AJPH.2011.300251","article-title":"Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations","volume":"101","author":"Drobnik","year":"2011","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.jim.2017.04.012_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s15010-009-9323-4","article-title":"Recent diarrhea is associated with elevated salivary IgG responses to cryptosporidium in residents of an eastern Massachusetts community","volume":"38","author":"Egorov","year":"2010","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.jim.2017.04.012_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/rmv.384","article-title":"Hepatitis E virus","volume":"13","author":"Emerson","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jim.2017.04.012_bb0075","first-page":"1","article-title":"Use of pathogen-specific antibody biomarkers to estimate waterborne infections in population-based settings","author":"Exum","year":"2016","journal-title":"Curr. Environ. Health Report"},{"issue":"1\u20132","key":"10.1016\/j.jim.2017.04.012_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jim.2010.11.005","article-title":"Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens","volume":"364","author":"Griffin","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2017.04.012_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jim.2015.05.001","article-title":"Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers","volume":"424","author":"Griffin","year":"2015","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.jim.2017.04.012_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-3024.1994.tb00303.x","article-title":"Toxoplasma gondii: detection of antibodies in human saliva and serum","volume":"16","author":"Hajeer","year":"1994","journal-title":"Parasite Immunol."},{"issue":"1","key":"10.1016\/j.jim.2017.04.012_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0168-8278(96)80323-0","article-title":"Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?","volume":"25","author":"Hamid","year":"1996","journal-title":"J. Hepatol."},{"issue":"13","key":"10.1016\/j.jim.2017.04.012_bb0100","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJMra1204512","article-title":"Hepatitis E","volume":"367","author":"Hoofnagle","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jim.2017.04.012_bb0105","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/jmv.21017","article-title":"Presence of hepatitis E virus in sewage in Northern India: frequency and seasonal pattern","volume":"79","author":"Ippagunta","year":"2007","journal-title":"J. Med. Virol."},{"issue":"9835","key":"10.1016\/j.jim.2017.04.012_bb0110","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.jim.2017.04.012_bb0115","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4269\/ajtmh.15-0159","article-title":"Two generations of \u201cgold standards\u201d: the impact of a decade in hepatitis E virus testing innovation on population seroprevalence","volume":"93","author":"Kmush","year":"2015","journal-title":"Am.J.Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.jim.2017.04.012_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/CMR.00062-13","article-title":"Host immune status and response to hepatitis E virus infection","volume":"27","author":"Krain","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.jim.2017.04.012_bb0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/oxfordjournals.epirev.a017994","article-title":"Hepatitis E: an emerging infectious disease","volume":"21","author":"Labrique","year":"1999","journal-title":"Epidemiol. Rev."},{"issue":"8","key":"10.1016\/j.jim.2017.04.012_bb0130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/aje\/kwq225","article-title":"Epidemiology and risk factors of incident hepatitis E virus infections in rural Bangladesh","volume":"172","author":"Labrique","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.jim.2017.04.012_bb0135","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3201\/eid1809.120241","article-title":"Hepatitis E, a vaccine-preventable cause of maternal deaths","volume":"18","author":"Labrique","year":"2012","journal-title":"Emerg. Infect. Dis. J."},{"issue":"1","key":"10.1016\/j.jim.2017.04.012_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(01)00169-4","article-title":"Novel methods for the detection of microbial antibodies in oral fluid","volume":"2","author":"McKie","year":"2002","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.jim.2017.04.012_bb0145","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/CDLI.11.6.1028-1034.2004","article-title":"Diagnosis of Norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant Norwalk virus antigen","volume":"11","author":"Moe","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"6","key":"10.1016\/j.jim.2017.04.012_bb0150","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2105\/AJPH.2004.054759","article-title":"Prevalence of HIV infection among young adults in the United States: results from the add health study","volume":"96","author":"Morris","year":"2006","journal-title":"Am. J. Public Health"},{"issue":"8","key":"10.1016\/j.jim.2017.04.012_bb0155","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/aje\/kwh107","article-title":"A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales","volume":"159","author":"Morris-Cunnington","year":"2004","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.jim.2017.04.012_bb0160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jcv.2013.10.010","article-title":"Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients","volume":"58","author":"Pas","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.jim.2017.04.012_bb0165","doi-asserted-by":"crossref","first-page":"O72","DOI":"10.1111\/1469-0691.12295","article-title":"Saliva as a source of anti-toxoplasma gondii IgG for enzyme immunoassay in human samples","volume":"20","author":"Sampaio","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.jim.2017.04.012_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/JCM.43.1.49-56.2005","article-title":"Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of Acute HEV infection","volume":"43","author":"Takahashi","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.jim.2017.04.012_bb0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/clinids\/14.4.961","article-title":"Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy","volume":"14","author":"Tsega","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jim.2017.04.012_bb0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/infdis\/jis688","article-title":"Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates","volume":"207","author":"Wenzel","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.jim.2017.04.012_bb0185","first-page":"667","article-title":"Comparison of the reliability of two ELISA kits for detecting IgM antibody against hepatitis E virus","volume":"42","author":"Zhou","year":"2008","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175917300091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175917300091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:05:47Z","timestamp":1602021947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175917300091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":37,"alternative-id":["S0022175917300091"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2017.04.012","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}